Delmonte RJ, Andrews B, LM Richards, et al. Treatment of HCV with direct acting antivirals significantly reduces liver-related hospitalizations in patients with cirrhosis. AASLD 2017, abstract 75.
Camrelizumab plus rivoceranib versus sorafenib als eerstelijnsbehandeling bij inoperabel HCC
nov 2023 | Hepatologie, Immuuntherapie, Maag-darm-leveroncologie